Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial is a research paper published in Blood (2022). On theSindex it has a DataRank of 0. It has been cited 41 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: K24 HL147017
NCATS NIH HHS
Grant: UL1 TR000445
NICHD NIH HHS
Grant: P50 HD103537
National Institutes of Health
Grant: 1K24HL147017-01
Mentoring in Patient-Oriented Research focused on Neurological Complications of Sickle Cell Disease
National Institutes of Health
Grant: 6UL1TR000445-11
The Vanderbilt Institute for Clinical and Translational Research (VICTR)
FWCI
4.78
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals